Institutional Manager · CIK 0002050709
Squadron Capital Management LLC
WESTMONT, IL · File #028-26573
Latest AUM
$236.0M
Positions
33
Top-10 Concentration
65.7%
Filings
1
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| NEW | RELMADA THERAPEUTICS INC | RLMD | +6,700,000 | +$32.4M | $0 |
| NEW | COGENT BIOSCIENCES INC | COGT | +780,000 | +$27.7M | $0 |
| NEW | MAZE THERAPEUTICS INC | MAZE | +490,000 | +$20.3M | $0 |
| NEW | ABIVAX SA | AAVXF | +145,000 | +$19.6M | $0 |
| NEW | KALVISTA PHARMACEUTICALS INC | KALV | +700,000 | +$11.3M | $0 |
| NEW | PALISADE BIO INC | PALI | +4,500,000 | +$10.6M | $0 |
| NEW | EDGEWISE THERAPEUTICS INC | EWTX | +350,000 | +$8.7M | $0 |
| NEW | INHIBIKASE THERAPEUTICS INC | IKT | +4,225,000 | +$8.7M | $0 |
| NEW | KODIAK SCIENCES INC | KOD | +291,710 | +$8.2M | $0 |
| NEW | TERNS PHARMACEUTICALS INC | TERN | +190,000 | +$7.7M | $0 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202533 pos · $236.0M
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | RELMADA THERAPEUTICS INC | RLMD | 6,700,000 | $32.4M | 13.71% |
| 2 | COGENT BIOSCIENCES INC | COGT | 780,000 | $27.7M | 11.74% |
| 3 | MAZE THERAPEUTICS INC | MAZE | 490,000 | $20.3M | 8.60% |
| 4 | ABIVAX SA | AAVXF | 145,000 | $19.6M | 8.29% |
| 5 | KALVISTA PHARMACEUTICALS INC | KALV | 700,000 | $11.3M | 4.79% |
| 6 | PALISADE BIO INC | PALI | 4,500,000 | $10.6M | 4.48% |
| 7 | EDGEWISE THERAPEUTICS INC | EWTX | 350,000 | $8.7M | 3.68% |
| 8 | INHIBIKASE THERAPEUTICS INC | IKT | 4,225,000 | $8.7M | 3.67% |
| 9 | KODIAK SCIENCES INC | KOD | 291,710 | $8.2M | 3.46% |
| 10 | TERNS PHARMACEUTICALS INC | TERN | 190,000 | $7.7M | 3.25% |
| 11 | ARRIVENT BIOPHARMA INC | AVBP | 338,000 | $6.8M | 2.88% |
| 12 | TARSUS PHARMACEUTICALS INC | TARS | 80,000 | $6.6M | 2.78% |
| 13 | UPSTREAM BIO INC | UPB | 230,650 | $6.3M | 2.65% |
| 14 | SPRUCE BIOSCIENCES INC | SPRB | 70,000 | $6.1M | 2.58% |
| 15 | XENON PHARMACEUTICALS INC | XENE | 105,551 | $4.7M | 2.00% |
| 16 | DBV TECHNOLOGIES S A | DBVTF | 240,000 | $4.6M | 1.95% |
| 17 | CYBIN INC | HELP | 525,000 | $4.3M | 1.82% |
| 18 | LIPOCINE INC NEW | LPCN | 530,000 | $4.3M | 1.80% |
| 19 | BELITE BIO INC | BLTE | 26,000 | $4.2M | 1.76% |
| 20 | GH RESEARCH PLC | GHRS | 315,000 | $4.0M | 1.70% |